Submitting OIG:
Report Description:
When Congress established average sales price (ASP) as the basis for Medicare Part B drug reimbursement, it also provided a mechanism for monitoring market prices and limiting potentially excessive payment amounts.
Date Issued:
Thursday, February 20, 2020
Agency Reviewed / Investigated:
Submitting OIG-Specific Report Number:
OEI-03-20-00040
Component, if applicable:
Centers for Medicare & Medicaid Services
Location(s):
Agency-Wide
Type of Report:
Inspection / Evaluation
View Document:
Attachment | Size |
---|---|
oei-03-20-00040.pdf | 82.36 KB |
Additional Details Link: